284 related articles for article (PubMed ID: 30279726)
1. ATP-activated decrosslinking and charge-reversal vectors for siRNA delivery and cancer therapy.
Zhou Z; Zhang Q; Zhang M; Li H; Chen G; Qian C; Oupicky D; Sun M
Theranostics; 2018; 8(17):4604-4619. PubMed ID: 30279726
[TBL] [Abstract][Full Text] [Related]
2. Charge and Assembly Reversible Micelles Fueled by Intracellular ATP for Improved siRNA Transfection.
Zhou Z; Li C; Zhang M; Zhang Q; Qian C; Oupicky D; Sun M
ACS Appl Mater Interfaces; 2018 Sep; 10(38):32026-32037. PubMed ID: 30179452
[TBL] [Abstract][Full Text] [Related]
3. Reversible Covalent Cross-Linked Polycations with Enhanced Stability and ATP-Responsive Behavior for Improved siRNA Delivery.
Zhou Z; Zhang M; Liu Y; Li C; Zhang Q; Oupicky D; Sun M
Biomacromolecules; 2018 Sep; 19(9):3776-3787. PubMed ID: 30081638
[TBL] [Abstract][Full Text] [Related]
4. Systemic siRNA Delivery with a Dual pH-Responsive and Tumor-targeted Nanovector for Inhibiting Tumor Growth and Spontaneous Metastasis in Orthotopic Murine Model of Breast Carcinoma.
Fan B; Kang L; Chen L; Sun P; Jin M; Wang Q; Bae YH; Huang W; Gao Z
Theranostics; 2017; 7(2):357-376. PubMed ID: 28042340
[TBL] [Abstract][Full Text] [Related]
5. Sialic Acid-Targeted Nanovectors with Phenylboronic Acid-Grafted Polyethylenimine Robustly Enhance siRNA-Based Cancer Therapy.
Ji M; Li P; Sheng N; Liu L; Pan H; Wang C; Cai L; Ma Y
ACS Appl Mater Interfaces; 2016 Apr; 8(15):9565-76. PubMed ID: 27007621
[TBL] [Abstract][Full Text] [Related]
6. Triton X-100-Modified Adenosine Triphosphate-Responsive siRNA Delivery Agent for Antitumor Therapy.
Fan X; Zhao X; Su W; Tang X
Mol Pharm; 2020 Oct; 17(10):3696-3708. PubMed ID: 32803981
[TBL] [Abstract][Full Text] [Related]
7. An effective tumor-targeting strategy utilizing hypoxia-sensitive siRNA delivery system for improved anti-tumor outcome.
Kang L; Fan B; Sun P; Huang W; Jin M; Wang Q; Gao Z
Acta Biomater; 2016 Oct; 44():341-54. PubMed ID: 27545812
[TBL] [Abstract][Full Text] [Related]
8. Dual-responsive polyplexes with enhanced disassembly and endosomal escape for efficient delivery of siRNA.
Zhu J; Qiao M; Wang Q; Ye Y; Ba S; Ma J; Hu H; Zhao X; Chen D
Biomaterials; 2018 Apr; 162():47-59. PubMed ID: 29432988
[TBL] [Abstract][Full Text] [Related]
9. Stimuli-responsive hybrid nanocarriers developed by controllable integration of hyperbranched PEI with mesoporous silica nanoparticles for sustained intracellular siRNA delivery.
Prabhakar N; Zhang J; Desai D; Casals E; Gulin-Sarfraz T; Näreoja T; Westermarck J; Rosenholm JM
Int J Nanomedicine; 2016; 11():6591-6608. PubMed ID: 27994460
[TBL] [Abstract][Full Text] [Related]
10. Polycation-detachable nanoparticles self-assembled from mPEG-PCL-g-SS-PDMAEMA for in vitro and in vivo siRNA delivery.
Lin D; Jiang Q; Cheng Q; Huang Y; Huang P; Han S; Guo S; Liang Z; Dong A
Acta Biomater; 2013 Aug; 9(8):7746-57. PubMed ID: 23624221
[TBL] [Abstract][Full Text] [Related]
11. ATP-Responsive Low-Molecular-Weight Polyethylenimine-Based Supramolecular Assembly via Host-Guest Interaction for Gene Delivery.
Jiang C; Qi Z; Jia H; Huang Y; Wang Y; Zhang W; Wu Z; Yang H; Liu J
Biomacromolecules; 2019 Jan; 20(1):478-489. PubMed ID: 30516950
[TBL] [Abstract][Full Text] [Related]
12. Phenylboronic acid-sugar grafted polymer architecture as a dual stimuli-responsive gene carrier for targeted anti-angiogenic tumor therapy.
Kim J; Lee YM; Kim H; Park D; Kim J; Kim WJ
Biomaterials; 2016 Jan; 75():102-111. PubMed ID: 26491998
[TBL] [Abstract][Full Text] [Related]
13. Polymeric nanoparticles for siRNA delivery and gene silencing.
Patil Y; Panyam J
Int J Pharm; 2009 Feb; 367(1-2):195-203. PubMed ID: 18940242
[TBL] [Abstract][Full Text] [Related]
14. CXCR4-targeted modular peptide carriers for efficient anti-VEGF siRNA delivery.
Egorova A; Shubina A; Sokolov D; Selkov S; Baranov V; Kiselev A
Int J Pharm; 2016 Dec; 515(1-2):431-440. PubMed ID: 27789364
[TBL] [Abstract][Full Text] [Related]
15. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.
Ma X; Zhao Y; Ng KW; Zhao Y
Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533
[TBL] [Abstract][Full Text] [Related]
16. Enhanced siRNA delivery and silencing gold-chitosan nanosystem with surface charge-reversal polymer assembly and good biocompatibility.
Han L; Zhao J; Zhang X; Cao W; Hu X; Zou G; Duan X; Liang XJ
ACS Nano; 2012 Aug; 6(8):7340-51. PubMed ID: 22838646
[TBL] [Abstract][Full Text] [Related]
17. Bioreducible crosslinked polyelectrolyte complexes for MMP-2 siRNA delivery into human vascular smooth muscle cells.
Lee D; Kim D; Mok H; Jeong JH; Choi D; Kim SH
Pharm Res; 2012 Aug; 29(8):2213-24. PubMed ID: 22477074
[TBL] [Abstract][Full Text] [Related]
18. A mesoporous silica nanoparticle--PEI--fusogenic peptide system for siRNA delivery in cancer therapy.
Li X; Chen Y; Wang M; Ma Y; Xia W; Gu H
Biomaterials; 2013 Jan; 34(4):1391-401. PubMed ID: 23164421
[TBL] [Abstract][Full Text] [Related]
19. pH-Switchable Coordinative Micelles for Enhancing Cellular Transfection of Biocompatible Polycations.
Zhang Q; Zhou Z; Li C; Wu P; Sun M
ACS Appl Mater Interfaces; 2019 Jun; 11(23):20689-20698. PubMed ID: 31117451
[TBL] [Abstract][Full Text] [Related]
20. Polyelectrolyte complexes of hTERT siRNA and polyethyleneimine: Effect of degree of PEG grafting on biological and cellular activity.
Safari F; Tamaddon AM; Zarghami N; Abolmali S; Akbarzadeh A
Artif Cells Nanomed Biotechnol; 2016 Sep; 44(6):1561-8. PubMed ID: 26232080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
